2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
2
Classical hematology
1
Conditions
Hemorrhage
13
Neoplasms
7
Leiomyoma
7
Breast Neoplasms
6
Postoperative Hemorrhage
4
Hematologic Neoplasms
4
Thrombocytopenia
3
Myofibroma
3
Meningioma
3
Blood Loss, Surgical
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Seroma
2
Seizures
2
Prostatic Neoplasms
2
Postoperative Complications
2
Ovarian Neoplasms
2
Menorrhagia
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Bone Neoplasms
2
Wrist Fractures
1
Urologic Diseases
1
Urinary Tract Infections
1
Urinary Retention
1
Thromboembolism
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Interventions
Levetiracetam
6
Cannabidiol
5
perampanel
2
Tranexamic Acid
2
Standard of Care
2
Everolimus
2
ziprasidone
1
enzalutamide
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Temozolomide
1
Spironolactone
1
Solutions
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Propofol
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Seizures
×
Tranexamic Acid
×
Clear all
NCT04595786
2025-03-04
STAMP
Beijing Tiantan Hospital
Phase NA
Completed
228 enrolled
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled